Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Hepatitis Monthly|December 6, 2011
Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literatureKrzysztof Gutkowski, Alina Chwist, Marek Hartleb
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 16, 2002
Drug-induced liver damage -- a three-year study of patients from one gastroenterological departmentMarek Hartleb, Lukasz Biernat, Anna Kochel
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|October 12, 2010
[Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease]Maciej Kohut, Marek Hartleb, Teresa Hartleb
World Journal of Gastroenterology|April 8, 2011
Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertensionMarek Hartleb, Krzysztof Gutkowski, Piotr Milkiewicz
Przeglad Gastroenterologiczny|April 17, 2018
Detection of hepatocellular carcinoma by tissue resonance interaction method (TRIM)Grzegorz Boryczka, Marek Hartleb, Małgorzata Janik
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 14, 2017
Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver diseaseMarek Waluga, Michał Kukla, Michał Żorniak, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|December 1, 2015
Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart?Michał Kukla, Marek Waluga, Brygida Adamek, et al.
Biomed Research International|August 15, 2014
Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis CMichał Kukla, Brygida Adamek, Marek Waluga, et al.
Gastrointestinal Endoscopy|January 12, 2024
The prospective validation of a scoring system to assess mucosal cleanliness during EGDMarcin Romańczyk, Bartosz Ostrowski, Magdalena Lesińska, et al.
Trials|June 10, 2024
Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trialNorbert Stefan, Marek Hartleb, Branko Popovic, et al.
Pageof 9